Cargando…

Design of the Advance Directives Cohort: a study of end-of-life decision-making focusing on Advance Directives

BACKGROUND: ADs are documents in which one can state one's preferences concerning end-of-life care, aimed at making someone's wishes known in situations where he/she is not able to do so in another manner. There is still a lot unclear about ADs. We designed a study aimed at investigating t...

Descripción completa

Detalles Bibliográficos
Autores principales: van Wijmen, Matthijs PS, Rurup, Mette L, Pasman, H Roeline W, Kaspers, Pam J, Onwuteaka-Philipsen, Bregje D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091542/
https://www.ncbi.nlm.nih.gov/pubmed/20346111
http://dx.doi.org/10.1186/1471-2458-10-166
_version_ 1782203273958129664
author van Wijmen, Matthijs PS
Rurup, Mette L
Pasman, H Roeline W
Kaspers, Pam J
Onwuteaka-Philipsen, Bregje D
author_facet van Wijmen, Matthijs PS
Rurup, Mette L
Pasman, H Roeline W
Kaspers, Pam J
Onwuteaka-Philipsen, Bregje D
author_sort van Wijmen, Matthijs PS
collection PubMed
description BACKGROUND: ADs are documents in which one can state one's preferences concerning end-of-life care, aimed at making someone's wishes known in situations where he/she is not able to do so in another manner. There is still a lot unclear about ADs. We designed a study aimed at investigating the whole process from the formulating of an AD to its actual use at the end of life. METHODS/DESIGN: The study has mixed methods: it's longitudinal, consisting of a quantitative cohort-study which provides a framework for predominantly qualitative sub-studies. The members of the cohort are persons owning an AD, recruited through two Dutch associations who provide the most common standard ADs in the Netherlands, the NVVE (Right to Die-NL), of which 5561 members participate, and the NPV (Dutch Patient Organisation), of which 1263 members participate. Both groups were compared to a sample of the Dutch general public. NVVE-respondents are more often single, higher educated and non-religious, while amongst NPV-respondents there are more Protestants compared to the Dutch public. They are sent a questionnaire every 1,5 year with a follow-up of at least 7,5 years. The response rate after the second round was 88% respectively 90% for the NVVE and NPV. Participants were asked if we were allowed to approach close-ones after their possible death in the future. In this way we can get insight in the actual use of ADs at the end of life, also by comparing our data to that from the Longitudinal Aging Study Amsterdam, whose respondents generally do not have an AD. DISCUSSION: The cohort is representative for people with an AD as is required to study the main research questions. The longitudinal nature of the study as well as the use of qualitative methods makes it has a broad scope, focusing on the whole course of decision-making involving ADs. It is possible to compare the end of life between patients with and without an AD with the use of data from another cohort.
format Text
id pubmed-3091542
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30915422011-05-11 Design of the Advance Directives Cohort: a study of end-of-life decision-making focusing on Advance Directives van Wijmen, Matthijs PS Rurup, Mette L Pasman, H Roeline W Kaspers, Pam J Onwuteaka-Philipsen, Bregje D BMC Public Health Study Protocol BACKGROUND: ADs are documents in which one can state one's preferences concerning end-of-life care, aimed at making someone's wishes known in situations where he/she is not able to do so in another manner. There is still a lot unclear about ADs. We designed a study aimed at investigating the whole process from the formulating of an AD to its actual use at the end of life. METHODS/DESIGN: The study has mixed methods: it's longitudinal, consisting of a quantitative cohort-study which provides a framework for predominantly qualitative sub-studies. The members of the cohort are persons owning an AD, recruited through two Dutch associations who provide the most common standard ADs in the Netherlands, the NVVE (Right to Die-NL), of which 5561 members participate, and the NPV (Dutch Patient Organisation), of which 1263 members participate. Both groups were compared to a sample of the Dutch general public. NVVE-respondents are more often single, higher educated and non-religious, while amongst NPV-respondents there are more Protestants compared to the Dutch public. They are sent a questionnaire every 1,5 year with a follow-up of at least 7,5 years. The response rate after the second round was 88% respectively 90% for the NVVE and NPV. Participants were asked if we were allowed to approach close-ones after their possible death in the future. In this way we can get insight in the actual use of ADs at the end of life, also by comparing our data to that from the Longitudinal Aging Study Amsterdam, whose respondents generally do not have an AD. DISCUSSION: The cohort is representative for people with an AD as is required to study the main research questions. The longitudinal nature of the study as well as the use of qualitative methods makes it has a broad scope, focusing on the whole course of decision-making involving ADs. It is possible to compare the end of life between patients with and without an AD with the use of data from another cohort. BioMed Central 2010-03-26 /pmc/articles/PMC3091542/ /pubmed/20346111 http://dx.doi.org/10.1186/1471-2458-10-166 Text en Copyright ©2010 van Wijmen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
van Wijmen, Matthijs PS
Rurup, Mette L
Pasman, H Roeline W
Kaspers, Pam J
Onwuteaka-Philipsen, Bregje D
Design of the Advance Directives Cohort: a study of end-of-life decision-making focusing on Advance Directives
title Design of the Advance Directives Cohort: a study of end-of-life decision-making focusing on Advance Directives
title_full Design of the Advance Directives Cohort: a study of end-of-life decision-making focusing on Advance Directives
title_fullStr Design of the Advance Directives Cohort: a study of end-of-life decision-making focusing on Advance Directives
title_full_unstemmed Design of the Advance Directives Cohort: a study of end-of-life decision-making focusing on Advance Directives
title_short Design of the Advance Directives Cohort: a study of end-of-life decision-making focusing on Advance Directives
title_sort design of the advance directives cohort: a study of end-of-life decision-making focusing on advance directives
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091542/
https://www.ncbi.nlm.nih.gov/pubmed/20346111
http://dx.doi.org/10.1186/1471-2458-10-166
work_keys_str_mv AT vanwijmenmatthijsps designoftheadvancedirectivescohortastudyofendoflifedecisionmakingfocusingonadvancedirectives
AT rurupmettel designoftheadvancedirectivescohortastudyofendoflifedecisionmakingfocusingonadvancedirectives
AT pasmanhroelinew designoftheadvancedirectivescohortastudyofendoflifedecisionmakingfocusingonadvancedirectives
AT kasperspamj designoftheadvancedirectivescohortastudyofendoflifedecisionmakingfocusingonadvancedirectives
AT onwuteakaphilipsenbregjed designoftheadvancedirectivescohortastudyofendoflifedecisionmakingfocusingonadvancedirectives